These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21927056)

  • 1. Painful rheumatoid arthritis.
    Smith HS; Smith AR; Seidner P
    Pain Physician; 2011; 14(5):E427-58. PubMed ID: 21927056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
    Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging therapeutics for rheumatoid arthritis.
    Bingham CO
    Bull NYU Hosp Jt Dis; 2008; 66(3):210-5. PubMed ID: 18937634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging biologic drugs for the treatment of rheumatoid arthritis.
    Puppo F; Murdaca G; Ghio M; Indiveri F
    Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective new biological therapies for rheumatoid arthritis.
    Senolt L; Vencovský J; Pavelka K; Ospelt C; Gay S
    Autoimmun Rev; 2009 Dec; 9(2):102-7. PubMed ID: 19328245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs.
    Pavelka K; Kavanaugh AF; Rubbert-Roth A; Ferraccioli G
    Rheumatology (Oxford); 2012 Jul; 51 Suppl 5():v12-21. PubMed ID: 22718922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab: new preparation. Rheumatoid arthritis: no therapeutic advance.
    Prescrire Int; 2004 Oct; 13(73):171-5. PubMed ID: 15499697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologics in early rheumatoid arthritis.
    de Vries-Bouwstra JK; Dijkmans BA; Breedveld FC
    Rheum Dis Clin North Am; 2005 Nov; 31(4):745-62. PubMed ID: 16287595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current therapies in rheumatoid arthritis: a Latin American perspective.
    Burgos-Vargas R; Catoggio LJ; Galarza-Maldonado C; Ostojich K; Cardiel MH
    Reumatol Clin; 2013; 9(2):106-12. PubMed ID: 23337169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologics in rheumatoid arthritis.
    Sharma PK; Hota D; Pandhi P
    J Assoc Physicians India; 2004 Mar; 52():231-6. PubMed ID: 15636315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of infections with biologic therapies for rheumatoid arthritis.
    Furst DE
    Semin Arthritis Rheum; 2010 Apr; 39(5):327-46. PubMed ID: 19117595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
    van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
    Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE).
    Bondeson J; Maini RN
    Int J Clin Pract; 2001 Apr; 55(3):211-6. PubMed ID: 11351775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of rheumatoid arthritis in the 21st century: targeting B-lymphocytes.
    Brezinschek HP; Brickmann K; Yazdani-Biuki B; Dörner T; Graninger WB; Brezinschek RI
    Wien Med Wochenschr; 2006 Jan; 156(1-2):61-7. PubMed ID: 16465615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infliximab in aggressive and refractory rheumatoid arthritis. A pilot study].
    Caramaschi P; Canestrini S; Biasi D; Carletto A; Scambi C; Scarperi A; Bambara LM
    Recenti Prog Med; 2002 Jan; 93(1):19-24. PubMed ID: 11850995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects.
    Iannone F; Trotta F; Montecucco C; Giacomelli R; Galeazzi M; Matucci-Cerinic M; Ferri C; Cutolo M; Maria Bambara L; Triolo G; Ferraccioli G; Valentini G; Lapadula G;
    Ann Rheum Dis; 2007 Feb; 66(2):249-52. PubMed ID: 16837489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
    Schwartzman S; Fleischmann R; Morgan GJ
    Arthritis Res Ther; 2004; 6 Suppl 2(Suppl 2):S3-S11. PubMed ID: 15228615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part I. Tumor necrosis factor alpha inhibitors].
    Swierkot J; Madej M
    Pol Merkur Lekarski; 2011 Apr; 30(178):283-8. PubMed ID: 21595176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4+CD25+ Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
    Xinqiang S; Fei L; Nan L; Yuan L; Fang Y; Hong X; Lixin T; Juan L; Xiao Z; Yuying S; Yongzhi X
    Biomed Pharmacother; 2010 Sep; 64(7):463-71. PubMed ID: 20359858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.